Zanidatamab
About
Therapy type: Targeted therapy
Therapy strategy: ER signaling inhibition
Mappings
NCI Thesaurus: Zanidatamab (ncit:C130010)
RxNorm: zanidatamab (rxcui:2698198, omop:1464766)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | HER2-positive | Intraductal Papillary Neoplasm of the Bile Duct | Zanidatamab | |
| EMA (1) FDA (1) | HER2-positive | Intracholecystic Papillary Neoplasm | Zanidatamab | |
| EMA (1) FDA (1) | HER2-positive | Cholangiocarcinoma | Zanidatamab |